COVID-19
Photo provided by the National Institute of Allergy and Infectious Diseases’s Rocky Mountain Laboratories.

CORONAVIRUS RESEARCH GUIDANCE

The University of Colorado Denver | Anschutz Medical Campus continues to closely monitor the outbreak of coronavirus disease, known as COVID-19. With the ongoing concern about the spread of this disease, and recent extension of federal and local guidance, the CU Anschutz Medical Campus has extended remote working until further notice, and all employees at CU Denver whose presence is not designated as critical are to continue to work remotely until further notice. Plans are underway for a gradual reconstitution of select on-campus research activity, and those included will be contacted directly.

As there are different considerations for vivarium, bench and clinical research, each research team or laboratory is best positioned to create a continuity plan that will meet their unique needs. The guidance below is provided to facilitate the development of that plan. Please remember that unit Continuity of Operations Plans (COOPs) are also required to be completed, which will help with this process. Please contact michael.bear@cuanschutz.edu with questions.

Learn more about the research community and its affiliated departments, and read about Thomas Flaig, MD, vice chancellor for research for CU Denver and the CU Anschutz Medical Campus, here.

MOST RECENT UPDATES

Previous Updates

NEXT STEPS

The university is following guidance from the Colorado Department of Public Health & Environment (CDPHE), CDC and other agencies. The individuals involved in planning the university’s response are working in consultation with experts from UCHealth, EHS (Environmental Health and Safety), University Emergency Management, the School of Medicine and others on campus to update the university’s existing pandemic response plan in the event of widespread U.S. community transmission of COVID-19 or announcement of a COVID-19 pandemic. Expect to see additional updates, including research specific FAQs via email, as well as updates to the university’s COVID-19 webpages.

For more information on clinical research, click here.

June 5, 2020 Update

Mark your calendars: Clinical Research Ramp Up Town Hall on Wednesday, June 17, 2020, from 11:30 a.m. - 1 p.m., more information to follow.

CU Anschutz clinical research space: Plans for activation of CU Anschutz space are currently under review in accordance with the clinical research reconstitution plan

CU Anschutz ramp up of clinical research: Step-by-step directions can be found here.

May 29, 2020 Update

Mark your calendars: Clinical Research Ramp Up Town Hall on Wednesday, June 17, 2020 from 11:30am - 1pm, more information to follow.

CU Anschutz clinical research space: Plans for activation of CU Anschutz space are currently under review in accordance with the clinical research reconstitution plan. If you manage CU Anschutz owned or managed space which will conduct any clinical research activity contact Alison Lakin to identify a COVID official.

CU Anschutz ramp up of clinical research: Step-by-step directions can be found here.

UCHealth only (no use or access needed to any CU Anschutz facilities), follow: UCHealth Guidelines for Research Involving Human Subjects During COVID-19 Outbreak, Update: May 21, 2020. If you have any questions, please contact UCH-ResearchAdmin@uchealth.org or  Laurie Blumberg Romero.

For CHCO only (no use or access needed to any CU Anschutz facilities): Requests can be submitted via: AMC Research Reactivation Survey. A webpage has been created so study teams can find guidance for prioritization, safety considerations, instructions for submission, top things to consider before returning to the hospital, etc.

May 22, 2020 Update

CU Anschutz clinical research space: Plans for activation are currently in development in accordance with the clinical research reconstitution plan. If you manage CU Anschutz owned or managed space which will conduct any clinical research activity contact Alison.Lakin@cuanschutz.edu to identify a COVID official.

Approval to open CU Anschutz space has to be in place before any applications for expansion of clinical research in that space can begin. As facilities on campus are approved to ramp up there will be additional announcements for the researchers to begin to submit their research protocols for re-activation. Currently, no new protocol can begin involving CU Anschutz space except for access to clinical sample management in RC1 or RC2.

Step by step directions for the CU Anschutz ramp up of clinical research can be found here.

UCHealth only (no use or access needed to any CU Anschutz facilities), follow:UCHealth Guidelines for Research Involving Human Subjects During COVID-19 Outbreak, Update: May 21, 2020. If you have any questions, please contact UCH-ResearchAdmin@uchealth.org or Laurie Blumberg Romero.

For CHCO only (no use or access needed to any CU Anschutz facilities): Requests can be submitted via: AMC Research Reactivation Survey. A webpage has been created so study teams can find guidance for prioritization, safety considerations, instructions for submission, top things to consider before returning to the hospital, etc.

June 5, 2020 Update

COVID Officials/COVID Plans: Research activity in the basic science spaces continues to expand. In the near term, onboarding of lab-based personnel will exceed 50% of baseline levels and plans for shift work are being developed by  each unit’s COVID officials. It will be critical that all physical distancing guidelines are followed and that occupancy of individual units cannot exceed 50% of the baseline census at any given time as the ramp up continues.

May 29, 2020 Update

COVID Officials/COVID Plans: Research activity in the basic science spaces continue to expand. In the near term, onboarding of lab-oriented personnel will exceed 50% of baseline levels and plans for shift work are being developed by each unit’s COVID officials. It will be critical that all physical distancing guidelines are followed and that occupancy of individual units cannot exceed 50% of the baseline census at any given time.

May 22, 2020 Update

COVID Officials/COVID Plans: For research occurring in the research towers, Barbara Davis Center, and School of Pharmacy, a total of 32 COVID plans for the first phase were submitted. Effective today, May 22 all submittals have been reviewed and approved. We are looking forward to the gradual return of our invited researchers back to campus and appreciate the careful planning and considerations that the COVID officials and researchers put into their COVID plans. Please be mindful of new traffic patterns and break room/kitchen rules in your work areas. We will continue to review new plans that come in from other laboratory research locations, including the Bioscience buildings. If you have questions, please reach out to your COVID official.

June 5, 2020 Update

OLAR: All researchers are reminded that they must complete the OLAR Research Restart Form to begin new experiments in the vivarium. As individuals are added to your laboratory plan after approval by the COVID official, please make sure to submit the OLAR Addition of Personnel Form to add them to your OLAR plan. More detail can be found in the OLAR specific communication.

May 29, 2020 Update

OLAR: All researchers are reminded that they must complete the OLAR Research Restart Form to begin new experiments in the vivarium. As individuals are added to your laboratory plan after approval by the COVID official, please make sure to submit the OLAR Addition of Personnel Form to add them to your OLAR plan. More detail can be found in the OLAR specific communication.

May 22, 2020 Update

OLAR: All researchers are reminded that they must complete the OLAR Research Restart Form to begin new experiments in the vivarium. Please remember that all individuals that will be entering the vivarium must be listed on this form, as well as in your individual lab and COVID Floor Plan. More detail can be found in the OLAR specific communication.